Bio intends to use the proceeds from the private placement toward advancing its preclinical cardiometabolic programs. ・This ...
Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Private placement securities continue to offer insurers attractive opportunities to enhance portfolio income, according to a recent Conning report. Conning’s latest Viewpoint commentary, “Private ...
COLLECTIVE METALS INC. (CSE: COMT | OTC: CLLMF | FSE: TO1) (the 'Company” or 'Collective”) is pleased to announce that it has amended the terms of its non-brokered private placement financing for ...